2-(3-isopropylphenyl)pyridine | 1314921-39-5

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(3-isopropylphenyl)pyridine
• 英文别名: 2-(3-propan-2-ylphenyl)pyridine
• CAS: 1314921-39-5
• 化学式: C₁₄H₁₅N
• mdl: MFCD07775660
• 分子量: 197.28
• InChiKey: KTIVRSGPQLWBBP-UHFFFAOYSA-N

物化性质

• 沸点：
  309.3±21.0 °C(Predicted)
• 密度：
  0.996±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.214
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  乙酰氧基氨基甲酸叔丁酯 、 2-(3-isopropylphenyl)pyridine 在 silver hexafluoroantimonate 、 carbonyl(pentamethylcyclopentadienyl)cobalt diiodide 作用下， 以 丙酮 为溶剂， 反应 16.0h， 以48%的产率得到tert-butyl [4-isopropyl-2-(pyridin-2-yl)phenyl]carbamate
  参考文献：
  名称：

  Cobalt(III)-Catalyzed C–H Amidation of Arenes using Acetoxycarbamates as Convenient Amino Sources under Mild Conditions

  摘要：

  The Co(III)-catalyzed direct C-H amidation of arenes has been developed using O-acylcarbamates as a convenient amino source. This reaction proceeded in high efficiency under external oxidant-free conditions with a broad range of arene substrates, including 6-arylpurines bearing sensitive functional groups, thus furnishing synthetically versatile arene N-carbamate products.

  DOI：

  10.1021/cs501860b
• 作为产物：
  描述：

  2-溴吡啶 、 3-异丙基苯硼酸 在 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 12.0h， 生成 2-(3-isopropylphenyl)pyridine
  参考文献：
  名称：

  N-Substituted Hydroxylamines as Synthetically Versatile Amino Sources in the Iridium-Catalyzed Mild C–H Amidation Reaction

  摘要：

  N-Substituted hydroxylamines such as aroyloxy- or acyloxycarbamates were successfully employed as synthetically versatile amino precursors in the iridium-catalyzed direct C-H amidation of arenes. The reaction proceeds smoothly at room temperature over a broad range of substrates with high functional group tolerance to afford N-substituted arylamine products.

  DOI：

  10.1021/ol501338h

文献信息

• SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
  申请人：GLAXOSMITHKLINE LLC

  公开号：US20150152108A1

  公开（公告）日：2015-06-04

  The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本发明涉及新型取代桥式脲化合物，相应的相关类似物，药物组合物以及其使用方法。本发明的抑制素调节化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和疾病，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块疾病、炎症、癌症和/或潮红有关的疾病或疾病，以及那些会受益于增加线粒体活性的疾病或疾病。本发明还涉及包含抑制素调节化合物与另一治疗剂组合的组合物。
• Visible‐Light‐Enabled Ruthenium‐Catalyzed <i>meta</i> ‐C−H Alkylation at Room Temperature
  作者：Parthasarathy Gandeepan、Julian Koeller、Korkit Korvorapun、Jens Mohr、Lutz Ackermann

  DOI：10.1002/anie.201902258

  日期：2019.7.15

  Visible‐light‐induced ruthenium catalysis has enabled remote C−H alkylations with excellent levels of position control under exceedingly mild conditions at room temperature. The metallaphotocatalysis occurred under exogenous‐photosensitizer‐free conditions and features an ample substrate scope. The robust nature of the photo‐induced mild meta‐C−H functionalization is reflected by the broad functional

  可见光诱导的钌催化在室温下非常温和的条件下实现了出色的位置控制水平的远程CH烷基化反应。金属光催化反应发生在无外源光敏剂的条件下，并且具有足够的底物范围。广泛的官能团耐受性反映了光诱导的轻度meta -C-H功能化的鲁棒性，并且可以以操作简单的方式进行反应，为挑战次级和叔meta -C-H奠定了基础钌光氧化还原催化进行烷基化反应。
• <i>meta</i> ‐Selective C−H Activation of Arenes at Room Temperature Using Visible Light: Dual‐Function Ruthenium Catalysis
  作者：Arunachalam Sagadevan、Michael F. Greaney

  DOI：10.1002/anie.201904288

  日期：2019.7.15

  Ruthenium‐catalyzed meta‐C−H activation of arenes at room temperature is reported to proceed under blue‐light irradiation. A variety of heteroarenes are compatible with this photochemical process, which leads to the corresponding meta C−C coupling products in good to very good yields. Initial mechanistic studies suggest a single‐electron transfer process occurs between a photoexcited RuII‐cyclometalated

  钌催化元在室温下芳烃的-C-H活化报道下蓝色光照射进行。多种杂芳基化合物与该光化学过程兼容，从而导致相应的间位C-C偶联产物的收率很高。最初的机理研究表明，光激发的Ru II环金属化配合物与卤代烷之间会发生单电子转移过程，从而可以通过碳中心自由基进行meta -C-H官能化反应。
• ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND
  申请人：Samsung Electronics Co., Ltd.

  公开号：US20210155647A1

  公开（公告）日：2021-05-27

  Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M(L 1 ) n1 (L 2 ) n2 Formula 1 wherein, in Formula 1, M, L 1 , L 2 , n1 and n2 may each be understood by referring to the descriptions thereof provided herein.

  提供了一个由公式1表示的有机金属化合物，包括该有机金属化合物的有机发光器件，以及包括该有机金属化合物的诊断组合物：M（L1）n1（L2）n2 在公式1中，M、L1、L2、n1和n2可以通过参考此处提供的描述来理解。
• RHO KINASE INHIBITORS
  申请人：Cook Brian Nicholas

  公开号：US20120165322A1

  公开（公告）日：2012-06-28

  The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R 1 and R 2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

  本发明涉及式(I)的化合物和其药学上可接受的盐，其中R1和R2的定义如本文所述。本发明还涉及包含这些化合物的药物组合物、使用这些化合物治疗各种疾病和障碍的方法、制备这些化合物的过程以及在这些过程中有用的中间体。